This year has been a rollercoaster for the pharmaceutical industry, and at this point, it’s unclear whether the ride is about to stop or if we’re at the top of another drop.

The industry overall has posted mixed earnings so far, with companies performing better than expected in some categories but falling short in others, Healthcare Brew previously reported.

So, though we regularly do roundups of people being appointed to new positions, this time we’re filling you in on some of 2025’s pharma layoffs so far.

Bayer. The Germany-based pharmaceutical company laid off about 2,000 employees worldwide in Q1, BioSpace reported in May.

Get the full picture here.—CC

Erika Rosato is an oncology nurse at Massachusetts General Hospital, and her day revolves around…paper.

She checks flow sheets at patients’ bedsides for vital signs. She writes on a clipboard when speaking with them, and then hunts down a binder at the nurses station to report her notes. But she has to wait if another provider, like a respiratory therapist, is already using it.

After wrapping up her notes, she takes handwritten orders from physicians—some with “better penmanship than others”—and transcribes them into orders. She checks, highlights, and initials her work in red.

But that was 25 years ago in 2000. Now, Rosato is the associate chief nurse for the Mass General Cancer Center’s Obstetrics, Pediatrics, and Medical Infusion Center.

Time travel back to the year 2000 here.—CM